Daraxonrasib for Pancreatic Cancer: What to Know
Daraxonrasib for Pancreatic Cancer: What to Know Mass General Brigham
Онкология
🎗️Лента новостей
Онкология
Urine test may improve bladder cancer diagnosis and guide treatment decisions
Urine test may improve bladder cancer diagnosis and guide treatment decisions Stanford Medicine
Онкология
Редкий рак глаза – британка рассказала, какие симптомы игнорировала
Редкий рак глаза – британка рассказала, какие симптомы игнорировала 5.ua
Онкология
Hidden lymphatic signal amplifier could inform treatments for lymphedema and cancer metastasis
Lymphatic vessels act as the body's "drainage system," collecting excess fluid from tissues. When lymphatic drainage is impaired because lymphatic vessels are underdeveloped, damaged or dysfunctional, lymphedema can develop, causing swelling, particularly in the arms and legs.
Онкология
BriaCell’s Bria-ABC Joins Roster of US-Enrolled Breast Cancer Trials
BriaCell’s Bria-ABC Joins Roster of US-Enrolled Breast Cancer Trials Investing News Network
Онкология
ESMO Calls for Abstract Submissions to Advance Breast Cancer Research
ESMO Calls for Abstract Submissions to Advance Breast Cancer Research Oncodaily
Онкология
Breast Cancer and Exercise: Should You Work Out During Treatment?
Breast Cancer and Exercise: Should You Work Out During Treatment? Everyday Health
🎗️
Онкология
FDA Decision on Ifinatamab Deruxtecan for Small Cell Lung Cancer Expected by Oct. 10
FDA Decision on Ifinatamab Deruxtecan for Small Cell Lung Cancer Expected by Oct. 10 Cure Today
Онкология
An epigenetic blueprint reveals how aggressive MYC amplification fuels cancer
Researchers at the Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center have discovered how to control and stop the amplification of MYC—one of the most commonly altered cancer genes linked to aggressive tumor growth and treatment resistance.
Онкология
Инфекции и рак: почти каждый восьмой случай онкозаболевания в мире вызван патогенами
Инфекции и рак: почти каждый восьмой случай онкозаболевания в мире вызван патогенами Medvestnik
Онкология
Bulletin: Encouraging early results for HR+/HER2+ breast cancer chemo-free treatment
Bulletin: Encouraging early results for HR+/HER2+ breast cancer chemo-free treatment Medical News Bulletin
Онкология
Protective drug dexrazoxane reduces heart damage in pediatric cancer survivors years after treatment ends
Protective drug dexrazoxane reduces heart damage in pediatric cancer survivors years after treatment ends medicaldialogues.in
🎗️
Онкология
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination WTVB
